Haining Li

Dr. Haining Li


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2023 in Brain and Behavior
Verified
Journal Article
Open access
YLYue Lv
Yue Lv
MWMengran Wang
Mengran Wang
JYJuan Yang
Juan Yang
JSJin Shi
Jin Shi
TXTingting Xuan
Tingting Xuan
HLHaining Li
Haining Li
Background: Propranolol, a nonselective beta‐adrenergic blocker, has long been used as one of the standard treatments for essential tremor (ET). Repetitive transcranial magnetic stimulation (rTMS) has also been used for a long time as a substitution therapy for ET patients.Objective: The main aim of this study was to evaluate the antitremor effect of 1‐Hz (low‐frequency) cerebellar rTMS and compare it to the use of propranolol in ET patients.Methods: In this single‐blinded, randomized, controlled pilot study, a total of 38 patients with ET were randomized into two groups. One group (n = 20) received 1200 pulses of 1‐Hz rTMS at an intensity of 90% of the resting motor threshold to the bilateral cerebellar region for 10 days. Another group (n = 18) received oral propranolol for 30 days. The initial dose was 30 mg/day, which was increased to 60 mg/day after 5 days, then to 90 mg/day on the 11th day, and continued thereafter for 20 days. The Fahn–Tolosa–Marin (FTM) clinical scale was assessed at baseline and at days 5, 10, and 30 to evaluate tremor severity, specific motor tasks, and functional disability.Results: Low‐frequency rTMS of the cerebellum significantly improved tremor severity, specific motor tasks (writing, spiral drawing, and pouring), and FTM total scores on days 10 and 30. Nevertheless, we found no significant difference in functional disability at any point in time (p > .05). There were no statistically significant differences in FTM Part A, Part B, Part C scores and total scores of patients in propranolol group on days 5 and 10 compared with before treatment (p > .05). However, FTM total scores and FTM Part A, Part B, and Part C scores were significantly improved for patients when the dose of propranolol was 90 mg/day on day 30. Our study showed that there was no statistically significant difference in the total FTM scores and FTM Part A, Part B, and Part C scores between rTMS and propranolol on days 5, 10, and 30 (p > .05).Conclusion: We conclude that both cerebellar low‐frequency rTMS and propranolol could be effective treatment options for patients with ET, but it is not clear which method is more effective.

16 August 2024 in Medicine
Verified
Journal Article
Open access
JHjianhang He
jianhang He
XNXiaoyan Mm Niu
Xiaoyan Mm Niu
XCXiaoyan Mm Chen
Xiaoyan Mm Chen
BMBoya Mm Ma
Boya Mm Ma
YRYazhou Mm Ren
Yazhou Mm Ren
HLHaining Li
Haining Li
Rationale: Anti-Myelin oligodendrocyte glycoprotein (MOG) and anti-metabotropic glutamate receptor 5 (mGluR5) double antibody positive encephalitis characterized by optic neuritis is extremely rare. We present a case of overlapping syndrome of MOG-IgG-associated disease and anti-mGluR5 encephalitis manifested as optic neuritis. Patient concerns: A 60-year-old Chinses woman presented to the hospital with progressive vision loss and headache for 1 week. The cerebrospinal fluid examination was within the normal range. Visual evoked potentials study disclosed prolonged latency of P100 bilaterally. Fundus examination revealed indistinct boundaries of both optic discs. Her brain magnetic resonance imaging showed patchy hyperintensity in the posterior horn of the left ventricle and the left optic nerve. Her serum was positive for anti-MOG and anti-mGluR5 antibodies. Diagnosis: The patient was diagnosed with overlapping syndrome of anti-MOG antibody-associated disease and anti-mGluR5 encephalitis mainly based on the clinical symptoms and further test of the antibody in serum. Interventions and outcomes: She was subsequently subjected to empirical treatment with intravenous methylprednisolone. After discharge, she was given a tapering dose of oral prednisone, alongside mycophenolate mofetil. On outpatient follow-up, her symptoms showed no relapse after 1 month, and her condition remained stable. Lessons: Early recognition of autoimmune encephalitis is crucial. The detection of cerebrospinal fluid and serum of autoimmune encephalitis and demyelinating diseases of the CNS, including MOG-IgG and mGluR5-IgG, should be strengthened in order to make a precise diagnosis and develop a comprehensive treatment plan in a timely manner.

11 July 2025 in Medicine
Verified
Journal Article
Open access
XZXueping Mm Zhang
Xueping Mm Zhang
XCXiaoyan Mm Chen
Xiaoyan Mm Chen
XNXiaoyan Mm Niu
Xiaoyan Mm Niu
TXTingting Xuan
Tingting Xuan
JHjianhang He
jianhang He
HLHaining Li
Haining Li
Rationale: Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is a central nervous system disorder driven by autoantibodies, characterized by a wide range of complex clinical manifestations. Although tumors, such as teratomas, and viral infections have been identified as potential triggering factors, the precise etiology of this condition remains to be elucidated. While herpes simplex virus type 1 (HSV-1) has been linked to the onset of anti-NMDAR encephalitis, cases involving coinfection with Epstein–Barr virus (EBV) and HSV-1 as causative factors are exceedingly rare. Patient concerns: A 46-year-old female patient who exhibited mental abnormalities, epileptic seizures, and altered consciousness. Analysis of cerebrospinal fluid samples revealed the presence of EBV and HSV-1 infections. The initial autoimmune encephalitis antibody test returned negative results. However, a subsequent test indicated the presence of anti-NMDAR antibodies in the cerebrospinal fluid, whereas serum analysis remained negative. Diagnoses: The patient was diagnosed with anti-NMDAR encephalitis resulting from infection with the EBV and HSV-1. Interventions and Outcomes: Antiviral treatments were administered to the patient in conjunction with intravenous methylprednisolone and human immunoglobulin pulse therapy. This initial treatment did not yield satisfactory results, and the patient’s condition remained critical, necessitating the introduction of rituximab for immunosuppressive therapy. Subsequently, the treatment regimen was adjusted to include intravenous tocilizumab, along with an intrathecal injection of 10 mg methotrexate and 10 mg dexamethasone. Ultimately, the patient’s clinical symptoms improved relative to their previous condition, and repeated examinations demonstrated a gradual decrease in the white blood cell count in the cerebrospinal fluid, indicating that the treatment was effective. Lessons: This case is the first diagnosed at our hospital and represents a rare instance in the literature of anti-NMDAR encephalitis directly triggered by co-infection with EBV and HSV-1. The diagnostic process emphasizes the need to maintain a high level of suspicion and repeat antibody tests in patients suspected of autoimmune encephalitis, even when initial antibody tests are negative.

9 July 2025 in Brain and Behavior
Verified
Journal Article
Open access
HLHaining Li
Haining Li
JHjianhang He
jianhang He
TXTingting Xuan
Tingting Xuan
SGShue Gu
Shue Gu
XNXiaoyan Niu
Xiaoyan Niu
JCJiang Cheng
Jiang Cheng
Background: The neuroimmune interaction mechanisms of neurodegenerative diseases have received increasing attention. Parkinson's disease (PD) is the second most common neurodegenerative disease, with potential immunoregulatory abnormalities. However, the causal roles of specific immune cell proteins remain unclear. Methods: We obtained PD and immune cell protein data from an open and free genome‐wide association study (GWAS) for subsequent analysis. Two‐sample MR analyses with inverse‐variance weighted (IVW), MR‐Egger regression, weighted median, and weighted mode methods were used to evaluate the causal effects. Sensitivity analyses incorporated Cochran's Q test for SNP heterogeneity (prioritizing IVW estimates when present) alongside MR‐Egger intercept and leave‐one‐out evaluations to address horizontal pleiotropy. Results: The IVW analysis revealed that the genetically predicted level of three immune cell proteins per standard‐deviation increase was positively associated with PD, including CD38 (OR = 1.13, 95%CI: 1.05–1.22, P = 0.001), FcγRIIIB (OR = 1.06, 95%CI: 1.01–1.11, P = 0.019), and CUL4B (OR = 1.11, 95% CI: 1.00–1.20, P = 0.012). The IVW analysis also revealed that the genetically predicted level of ADAMTSs per standard‐deviation increase was inversely associated with PD (OR = 0.89, 95% CI: 0.81–0.98, P = 0.013). Conclusions: We demonstrate that CD38, FcγRIIIB, and CUL4B are risk factors for PD, whereas ADAMTSs is a protective factor.

11 May 2023 in Research Square
Verified
Preprint
Open access
PDF file
XFXue Fang
Xue Fang
SGShue Gu
Shue Gu
JZJunmei Zhang
Junmei Zhang
DDDandan DU
Dandan DU
SCShuhong Chi
Shuhong Chi
HLHaining Li
Haining Li
Objective To study the symptoms, clinical manifestations, laboratory tests, imaging, treatment and prognosis of neuromyelitis optica (NMOSD) with or without combined connective tissue disease (CTD). Methods The 226 NMOSD patients diagnosed at Ningxia Medical University General Hospital were divided into two groups according to the presence or absence of concurrent CTD. The clinical data and prognosis of NMOSD patients with combined CTD were analyzed and followed up. At the same time, NMOSD patients with combined CTD were compared with NMOSD patients without the presence of CTD in terms of laboratory tests, imaging tests, and the similarities and differences between the two groups were analyzed. Results CTD combined with NMOSD mostly occurred in females, and the most prevalent form of CTD is systemic lupus erythematosus (SLE) or primary Sjögren's syndrome (pSS). It has a variety of symptoms, the majority of which are visual loss or limb weakness and numbness, and the majority of patients are positive for AQP4-IgG. The symptoms resolve significantly after sequential hormonal shock therapy in the acute phase, but the relapse rate is high. Meanwhile, it was revealed that when compared between NMOSD patients with combined CTD and NMOSD patients without combined CTD, there was a significant difference between the recurrent events (including recurrence rate and number of recurrences) and degree of remission (p<0.05). Conclusions The high incidence of CTD combined with NMOSD in women and the high recurrence rate suggest that adjuvant immunosuppression should be given to further reduce recurrence.

4 March 2024 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
JHJianhang He
Jianhang He
YRYazhou Ren
Yazhou Ren
WQWeimin Qi
Weimin Qi
JYJuan Yang
Juan Yang
HLHaining Li
Haining Li